281-296-7300

  • Awards
  • Careers
logo
  • About
    • About VGXI
    • Leadership
    • VGXI Mission
    • Awards
    • Careers
  • Services
    • Manufacturing Services
    • cGMP Plasmid
    • HD Plasmid
    • Pre-Clinical Plasmid
    • Additional Services
  • VGXI Process
    • VGXI Manufacturing Process
    • Analytical Testing
    • Quality Systems
  • Resource Center
    • News
    • Events
    • FAQs
    • Whitepapers
    • Posters & Presentations
  • Contact Us
  • Awards
  • Careers

DNA prime/mixed VLP vaccination shows promise against HIV-1

DNA prime/mixed VLP vaccination shows promise against HIV-1

January 13, 2011

This study confirms that enhanced cellular immune responses result in mice via chimaeric Gag VLPs incorporating GagRT and GagTN as vaccine boost candidates to a pVRCgrttnC DNA priming vaccine for HIV-1. The DNA prime/mixed VLP boost vaccination increased the cumulative Gag- and RT-specific IFN-γ responses relative to two DNA vaccinations 4-fold, and Gag- and RT-specific IL-2 responses 2.8 fold. Chimaeric VLP boosts such as these are a promising option for future HIV-1 vaccine studies.

Sirika Pillay, Enid G Shephard, Ann E Meyers, Anna-Lise Williamson, Edward P Rybicki.
“HIV-1 sub-type C chimaeric VLPs boost celluar immune responses in mice.”
Journal of Immune Based Therapies and Vaccines 2010.

Filed Under: Blog, Uncategorized

Archives

  • 2023
  • 2022
  • 2021
  • 2020
  • 2019
  • 2018
  • 2017
  • 2016
  • 2015
  • 2014
  • 2013
  • 2012
  • 2011
  • 2010
  • 2009
  • 2008
  • 2007
  • About
  • Services
  • VGXI Process
  • Contact Us
  • Careers
  • Awards
  • Resource Center
logo white

281-296-7300
2700 Research Forest Drive, Suite 180
The Woodlands, Texas 77381, USA

Teko Font
Please enter your name.
Please enter a valid email address.
Sign Up

Thanks for subscribing! Please check your email for further instructions.

Something went wrong. Please check your entries and try again.

© 2021 VGXI, Inc. All Rights Reserved.Terms | Privacy Policy